Timeliness-incentive home health management for metabolic dysfunction-associated steatotic liver disease

Table 3 Comparison of body mass index and biochemical indexes before and after interventions in the control and experimental groups, n (%)/mean ± SD/median (P25, P75)

Item	Experimental group (n = 54)		Control group (n = 54)		2 groups before intervention		2 groups after intervention
	Pre-intervention	Post-intervention	Pre-intervention	Post-intervention	X1/T1/Z1	P1 value	X2/T2/Z2	P2 value
Abdominal circumference	90.02 ± 11.72	78 (73, 83.25)	87.57 ± 8.35	82 (80, 85)	1.251	0.215	-2.972	0.003
BMI (kg/m2)	27.72 ± 5.17	24.83 (23.8, 27.2)	26.5 ± 1.85	25.01 (24.33, 25.87)	1.531	0.130	-0.382	0.703
Fatty liver grading					1.253	0.215	-2.673	0.008
Normal	0	8 (14.8)	0	2 (3.7)
Mild	18 (33.3)	26 (48.1)	14 (25.9)	19 (35.2)
Moderate	30 (55.6)	17 (31.5)	33 (61.1)	28 (51.8)
Severe	6 (11.1)	3 (5.6)	7 (13)	5 (9.3)
ALT (U/L)	26 (22, 32.25)	22 (18, 28.25)	23.5 (18.75, 28)	30.5 (26, 35.25)	-1.922	0.055	-4.802	< 0.001
AST (U/L)	32 (22.75, 50.25)	20 (18.75, 22)	27 (20, 42.5)	20 (19, 22.25)	-1.392	0.165	-0.802	0.425
TG (mmol/L)	2.04 (1.43, 2.67)	1.36 (1.13, 1.99)	1.85 (1.28, 2.85)	2.12 (1.53, 2.36)	-0.502	0.617	-3.302	0.001
TC (mmol/L)	5.24 ± 0.93	4.02 (3.23, 4.25)	5.05 ± 0.78	4.55 (3.95, 4.87)	1.121	0.266	-4.332	< 0.001
LDL-C (mmol/L)	3.10 ± 0.72	2.22 (2.09, 2.69)	2.94 ± 0.70	2.65 (2.29, 2.98)	1.151	0.250	-5.572	< 0.001
HDL-C (mmol/L)	1.19 ± 0.16	1.55 (1.43, 1.7)	1.19 ± 0.16	1.33 (1.16, 1.45)	0.731	0.469	-2.842	0.004

¹Data checked with the Student’s t test.

²Data checked with the Mann-Whitney U test.

³Data checked with the χ² test.

BMI: Body mass index; AST: Aspartate aminotransferase; ALT: Alanine aminotransferase; TG: Total triglyceride; TC: Total cholesterol; LDL-C: Low-density lipoprotein cholesterol; HDL-C: High-density lipoprotein cholesterol.